1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. REPLIMUNE GROUP INC
Replimune Group Inc
XNAS: REPL
2.0M
XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Replimune Grp Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Replimune Grp Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEUTRAL

    Quarterly Revenue Replimune Grp Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Quarterly Net Profit Replimune Grp Inc Jun-2026 Quarterly Net Profit is $-70 Million which is growth of 19.5% YoY.

Replimune Group Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
6872.971.583.99078.865.658.556.958.156.163.455.3
Operating Profit
-68-72.9-71.5-83.9-90-78.8-65.6-58.5-56.9-58.1-56.1-63.4-55.3
-3.1-2.9-2-2-2-2-2-2-2-2-1.6-1.5-1.7
Profit Before Tax
-69.8-73.5-71.2-83.1-86.7-74.2-65.8-53.1-53.8-55.1-50.7-60.2-49.4
Tax
--0.2-0.3---0.10.6-0.10.5-0.20.2
⌄
-69.8-73.2-70.9-83.1-86.7-74.1-66.3-53.1-53.8-55.1-51.1-60-49.6
Diluted NI Avail to Com Stockholders Ann.
-69.8-73.2-70.9-83.1-86.7-74.1-66.3-53.1-53.8-55.1-51.1-60-49.6
Basic EPS
-0.7-0.8-0.8-0.9-1-0.8-0.8-0.7-0.8-0.8-0.8-0.9-0.8
Diluted EPS After ExtraOrdinary
-0.7-0.8-0.8-0.9-1-0.9-0.8-0.8-0.9-0.9-0.8-1-0.8
Number Of Shares End
96.995.692.291.991.590.983.578.669.266.766.766.666.4
Net Income Continuing Discontinued Operations
-69.8-73.2-70.9-83.1-86.7-74.1-66.3-53.1-53.8-55.1-51.1-60-49.6
Normalized Income
-62.7-65.2-64.5-75.6-77.3-66.9-56.9-46.4-44.7-46.6-45.7-49.6-43.7
Interest Income
-------------
Interest
3.12.9222222221.61.51.7
Net Interest Income
-3.1-2.9-2-2-2-2-2-2-2-2-1.6-1.5-1.7
EBIT
-66.7-70.6-69.3-81.1-84.7-72.3-63.8-51.1-51.8-53.2-49.1-58.8-47.7
EBITDA
-65.7-69.8-68.4-79.6-83.8-71.4-62.8-49.5-51.1-52.5-48.4-58.1-47.1
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
0.90.80.90.80.90.910.90.70.70.70.70.6
Profit From Continuing Operations
-69.8-73.2-70.9-83.1-86.7-74.1-66.3-53.1-53.8-55.1-51.1-60-49.6
Normalized EBITDA
-67.7-72.2-71.3-84-88.5-77.3-67.9-55.6-55.8-57.9-54.1-64.1-53.3
*All financials are in USD Million and price data in USD

Replimune Grp Inc competitor comparison and performance snapshot within industry

Replimune Grp Inc annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

  • NEUTRAL

    Annual Revenue Replimune Grp Inc Annual Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Annual Net Profit Replimune Grp Inc Annual Net Profit is $-314 Million which is growth of -26.9% YoY.

Replimune Group Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17
-
-
 
Cost Of Rev. Ann.
-
-
 ----------
Gross Profit Ann.
-
-
 ----------
Operating Exp. Ann.
22.3%
32.8%
296.3318.3259.9232.9174.2115.177.253.128.4178.2
Operating Profit Ann.
-
-
-296.3-318.3-259.9-232.9-174.2-115.1-77.2-53.1-28.4-17-8.2
-
-
-10-8.9-7.9-6.7-4.2-2.2-3.1-1.92.60.30
Other Exp. Ann.
43.5%
-
 12.720.924.14.3-0.7-0.72.4-5-30.5
PBT Ann.
-
-
-297.6-314.5-246.8-215.4-174-118-80.9-52.6-30.8-19.7-7.7
Tax Ann.
-
-
 -0.60.50.40.3------
⌄
-
-
-297-313.9-247.3-215.8-174.3-118-80.9-52.6-30.8-19.7-7.7
Diluted NI Avail to Com Stockholders Ann.
-
-
-297-313.9-247.3-215.8-174.3-118-80.9-52.6-30.8-19.7-7.7
EPS Ann.
-
-
 -3.4-3.1-3.2-3-2.3-1.8-1.5-1.3-0.9-0.4
Diluted EPS Ann.
-
-
 -3.4-3.1-3.2-3-2.3-1.8-1.5-1.3-0.9-0.4
Number Of Shares End
13.1%
13.1%
 95.690.966.76652.551.738.831.521.5-
Total Exp. Ann.
22.3%
32.8%
 318.3259.9232.9174.2115.177.253.128.4178.2
Net Income Continuing Discontinued Operations Ann.
-
-
-297-313.9-247.3-215.8-174.3-118-80.9-52.6-30.8-19.7-7.7
Normalized Income Ann.
-
-
-268-282.5-219.8-189.4-147.6-93.8-68.2-44.9-22.7-17.9-7.4
Interest Income Ann.
-
-
 -------2.60.30
Interest Ann.
28.4%
23.5%
108.97.96.74.22.23.11.9---
EBITDA Ann.
-
-
-283.6-302.3-235.4-206.1-167.4-113.7-76.1-50.2-33.3-19.9-7.6
Reconciled Cost Of Rev. Ann.
-
-
 ----------
Reconciled Depr. Ann.
9.7%
14.2%
3.43.33.52.72.52.21.70.50.20.10.1
Profit From Continuing Operations Ann.
-
-
-297-313.9-247.3-215.8-174.3-118-80.9-52.6-30.8-19.7-7.7
Normalized EBITDA Ann.
-
-
-295.1-315.9-256.6-229.4-177.4-114.1-76.1-52.6-22.8-15.9-7.9
*All financials are in USD Million and price data in USD
Operating Exp. Ann.
1Y CHG
22.5%
2Y CAGR
16.9%
3Y CAGR
22.3%
5Y CAGR
32.8%
7Y CAGR
41.2%
Operating Expenses Annual Cr growth is stable compared to historical averages.

Replimune Grp Inc balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund Replimune Grp Inc Mar-2026 Total Shareholders Fund is $166 Million which is growth of -60.0% YoY.

  • NEGATIVE

    Total Assets Replimune Grp Inc Mar-2026 Total Assets is $332 Million which is growth of -39.7% YoY.

Replimune Group Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17
-19.9%
-9.4%
332.4551.3487.7646.6461.2543.1234.1154.365.222.8
⌄
22.1%
30.2%
166.2135.5113.291.35044.450.416.593.234.3
⌄
-33.1%
-19.7%
166.2415.8374.5555.3411.2498.7183.7137.9-28.1-11.5
Total Capitalization Ann.
-24.7%
-12.9%
249.5462.2419.3583.9411.2498.7193.5137.9-28.1-11.5
Tangible Assets Ann.
-33.1%
-19.7%
166.2415.8374.5555.3411.2498.7183.7137.9-28.1-11.5
Working Capital Ann.
-26.6%
-14%
220.9433.5393.2558.8383.2469.2162.4131.159.520.4
Invested Capital Ann.
-24.7%
-12.9%
249.5462.2419.3583.9411.2498.7193.5137.9-28.1-11.5
Tangible Book Value Ann.
-33.1%
-19.7%
166.2415.8374.5555.3411.2498.7183.7137.9-28.1-11.5
Borrowings Ann.
22.4%
27.4%
111.676.275.960.832.833.341.8---
Net Debt Ann.
-
-
----------
Share Issued Ann.
13.4%
12.2%
82.777.161.456.747.346.636.731.730.830.8
Number Of Shares End
13.1%
13.1%
95.690.966.76652.551.738.831.521.5-
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
-39.7%
2Y CAGR
-17.4%
3Y CAGR
-19.9%
5Y CAGR
-9.4%
7Y CAGR
11.6%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-6.7%
2Y CAGR
20%
3Y CAGR
19.9%
5Y CAGR
31.9%
7Y CAGR
28.8%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-60%
2Y CAGR
-33.4%
3Y CAGR
-33.1%
5Y CAGR
-19.7%
7Y CAGR
2.7%
Total ShareHolders Funds Annual is falling faster than historical averages.

Replimune Grp Inc ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

  • NEGATIVE

    Book Value Per Share Replimune Grp Inc Book Value Per Share is $1 which is growth of -74.0% YoY.

  • POSITIVE

    ROE Replimune Grp Inc ROE is -108% which is growth of 45.3% YoY.

Replimune Group Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17
RoA Ann. %
-
-
-71.05%-47.60%-38.05%-31.47%-23.51%-20.81%-27.10%-28.10%-44.79%-33.76%
ROE Ann. %
-
-
-107.88%-62.58%-46.42%-36.06%-25.94%-23.70%-32.73%-56.17%-81.38%-
ROIC %
-
-
-24.9-13.7-11.2-7.5-6.8-3.9-6.4-5.3-11.8-
OPM Ann. %
-
-
----------
Inventory Turnover Ratio Ann.
-
-
----------
Asset Turnover Ann. %
-
-
----------
Working Capital Turnover Ann.
-
-
Quick Ratio Ann.
-35.2%
-32.3%
4.77.810.517.319.23314.413.912.411.1
Current Ratio Ann.
-35%
-32.1%
4.8810.717.519.533.314.714.312.511.3
Interest Coverage Ratio Ann.
-
-
-34.5-30.3-31.3-40.8-52.1-25.4-26.4---
LT Debt To Equity Ann.
91.3%
47.6%
0.70.20.20.10.10.10.2---
*All financials are in USD Million and price data in USD
Current Ratio Ann.
1Y CHG
-40%
2Y CAGR
-33%
3Y CAGR
-35%
5Y CAGR
-32.1%
7Y CAGR
-14.4%
Current Ratio Annual is falling faster than historical averages.

Replimune Grp Inc cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Replimune Grp Inc Cash From Operating Activity is $-280 Million which is growth of -45.8% YoY.

  • POSITIVE

    Net Cash Flow Replimune Grp Inc Net Cash Flow is $97 Million which is growth of 166.3% YoY.

Replimune Group Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17
-
-
-280.3-192.3-185.5-128.1-82.2-61.4-60.6-25.4-16-7.1
-
-
310.8-23.897.2-142.5-1.8-188.8-5.2-65.9-44.1-0.2
-40.3%
-29.2%
66.3252.416.3311.36.6372.5100.2101.454.815
Cash Plus Cash Eqv. End Of Year Ann.
12.4%
2.7%
210.7112.876.2148.2107.6184.261.126.917.620.7
Net Increase In Cash Plus Cash Eqv.s Ann.
33.4%
-4.6%
96.836.4-7240.8-77.4122.334.410.1-5.37.7
Cash Plus Cash Eqv. Begin Of Year Ann.
1.6%
13%
112.876.2148.2107.6184.261.126.917.720.614.4
Income Tax Paid Supplemental Data Ann.
-
-
00.10.30.1-----
Interest Paid Supplemental Data Ann.
62.3%
50.9%
4.74.231.10.60.6---
Capex Ann.
-
-
-4.2-6.7-5.7-2.3-2.3-2.4-6.5-2.6-0.1-0.2
Issuance Of Capital Stock Ann.
-45%
-35.8%
31.2155.7187.3286.161.9103.354.815
Issuance Of Debt Ann.
7.5%
-
351528.2--10---
Repayment Of Debt Ann.
-
-
-0.7-0.6-0.5-0.4-0.3-10.1-0.1---
Repurchase Of Capital Stock Ann.
-
-
----------
Free Cash Flow Ann.
-
-
-284.6-198.9-191.1-130.3-84.5-63.8-67.1-28-16.2-7.3
*All financials are in USD Million and price data in USD
Cash from Investing Act. Ann.
2Y CAGR
78.8%
Cash from Investing Activity Annual growth is higher than historical averages.
Cash from Financing Act. Ann.
1Y CHG
-73.7%
2Y CAGR
101.7%
3Y CAGR
-40.3%
5Y CAGR
-29.2%
7Y CAGR
-5.9%
Cash from Financing Annual Activity is falling faster than historical averages.